TCL Archive Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer February 25, 2011
TCL Archive With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent November 18, 2011